Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?

Journal of Obstetrics and Gynaecology Research

Volumn 30, Issue 3, 2004, Pages 181-187

  Guleria, Kiran ^a,b   Agarwal, Neera ^a   Mishra, Kiran ^a   Gulati, Rachna ^a   Mehendiratta, Anita ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b Green Park Main   (India)

Author keywords

Cell mitosis; Cu T; Endometrial cancer; Ki67; Steroid receptors

Indexed keywords

COPPER INTRAUTERINE DEVICE; ESTRADIOL; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOHISTOCHEMISTRY; MITOSIS RATE; NORMAL HUMAN; PROGESTERONE BLOOD LEVEL; RADIOIMMUNOASSAY;

ADULT; CELL DIVISION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTRADIOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAUTERINE DEVICES, COPPER; KI-67 ANTIGEN; MITOSIS; PROGESTERONE; PROTECTIVE AGENTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 3042748166     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2004.00182.x     Document Type: Article

References (20)

1. Population Reports. IUDs - An update, Series B, No. 6. Baltimore: Dr Jain Clinic Pvt. Ltd, New Delhi for the Johns Hopkins University School of Hygiene and Public Health.
2. Sturgeon SR, Brinton LA, Berman ML et al. Intrauterine device use and endometrial cancer risk. Int J Epidemiol 1997; 26(3): 496-500.
3. Castellsague X, Thompson WD. Intrauterine contraception and the risk of endometrial cancer. Int J Cancer 1993; 54: 911-916.
4. Parazzini F, Veechia C. Intrauterine device use and risk of endometrial cancer. Br J Cancer 1994; 70: 672-677.
5. El-Badrawi HH, Hafez ES, Barnhart MI, Fayad M, Shafeek A. Ultrastructural changes in human endometrium with copper and non medicated IUDs in utero. Fertil Steril 1981; 36(1): 41-49.
6. Sheppard BL. Endometrial morphological changes in IUD users. A Review. Contraception 1987; 36: 1-10.
7. Hsu CL. Uterine malignancy developing after long term use of IUCD. Asia Oceanic J Obstet Gynaecol 1984; 10(3): 347-357.
8. Rosenblatt KA. WHO collaborative study of Neoplasia and Steroid contraceptives. Intrauterine device use and endometrial cancer. Am Epidemiol 1994; 139: 536.
9. Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002; 57(2): 120-128.
10. Hill DA, Weiss NS, Voigt LF, Beresford SA. Endometrial cancer in relation to intra-uterine device use. Int J Cancer 1997; 70(3): 278-281.
11. Rosenblatt KA, Thomas DB. Intrauterine devices and endometrial cancer. The WHO collaborative study of neoplasia and steroid contraceptives. Contraception 1996; 54(6): 329-332.
12. Mayachi K, Fritzle MJ, Tan EM. Antibody to a nuclear antigen in proliferating cells. J Immunol 1978; 121: 2208.
13. Ortiz Me Croxatio HB. Mechanism of action of intrauterine devices. Obstet Gynecol Surv 1996; 51(12): 542-551.
14. Sammour MB, Iskander SG. Combined histologic and cytologic study of intrauterine contraception. Am J Obstet Gynecol 1967; 98(7): 946-956.
15. Jones RW, Gregson NM. Effect of copper containing intrauterine contraceptive device on human cells in culture. Br Med J 1973; 2: 520-523.
16. Oster GK. Chemical reactions of the copper intrauterine device. Fertil Steril 1972; 23: 500-503.
17. Tamaya T, Nakata Y, Ohno Y, Nioka S, Furuta N. The mechanism of action of the copper intrauterine device. Fertil Steril 1976; 27(7): 767-772.
18. Myatt L, Chaudhuri G, Elder MG, Lim L. The estrogen receptor in the rat uterus in relation to intra uterine devices and the oestrous cycle. Biochem J 1978; 176: 523-529.
19. Punnonen R, Pettersson K, Vanharanta R. Androgen, estrogen and progestin cytosol receptor concentrations in the normal human endometrium. Effects of intrauterine device. Gynecol Obstet Invest 1984; 17(2): 73-77.
20. Janne O, Ylostalo P. Endometrial estrogen and progestin receptors in women bearing a progesterone-releasing intrauterine device. Contraception 1980; 22(1): 19-23.